References
- 1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available at: http://globocan.iarc.fr, last accessed on 23/01/2017.
- 2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013; 49(6):1374-403.10.1016/j.ejca.2012.12.027
- 3. Richart RM. Cervical intraepithelial neoplasia. Pathol Annu.1973; 8:301-28.
- 4. Lorincz AT, Reid R, Jensen AB, et al. Human papillomavirus infection of the cervix; Relative risk associations of 15 common anogenital types. Obstet Gynecol. 1992;39(2):152.10.1016/0020-7292(92)90921-5
- 5. Zuna RE, Wang SS, Schiffman M, et al. Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion. Cancer. 2006; 108(5):288-97. DOI: 10.1002/cncr.22168.10.1002/cncr.22168
- 6. Yim EK, Park JS. The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer Res Treat. 2005; 37(6):319-24. DOI: 10.4143/crt.2005.37.6.319.10.4143/crt.2005.37.6.319
- 7. Gewin L, Galloway DA. E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc. J. Virol 2001. 75:7198-201. DOI: 10.1128/JVI.75.15.7198-7201.2001.10.1128/JVI.75.15.7198-7201.2001
- 8. Oh, ST, Kyo S, Laimins LA. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites. J Virol. 2001; 75:5559-66. DOI: 10.1128/JVI.75.12.5559-5566.2001.10.1128/JVI.75.12.5559-5566.2001
- 9. Veldman T, Horikawa I, Barrett JC, et al. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J Virol. 2001. 75:4467-72. DOI: 10.1128/JVI.75.9.4467-4472.2001.10.1128/JVI.75.9.4467-4472.2001
- 10. Chen CH, Chen RJ. Prevalence of telomerase activity in human cancer. J Formos Med Assoc. 2011; 110(5):275-89. DOI:10.1016/S0929-6646(11)60043-0.10.1016/S0929-6646(11)60043-0
- 11. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science. 1995; 269:1236-41. DOI: 10.1126/science.7544491.10.1126/.7544491
- 12. Kilian A, Bowtell DD, Abud HE, et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet. 1997; 6:2011-9.10.1093/hmg/6.12.20119328464
- 13. Gardano L, Holland L, Oulton R, et al. Native gel electrophoresis of human telomerase distinguishes active complexes with or without dyskerin. Nucleic Acids Res. 2012; 40(5):e36. DOI:10.1093/nar/gkr1243.10.1093/nar/gkr1243
- 14. Collins K. Structure and function of telomerase. Curr Opin Cell Biol. 1996; 8:374–80. DOI: 10.1016/S0955-0674(96)80013-5.10.1016/S0955-0674(96)80013-5
- 15. Hiyama E, Tatsumoto N, Kodama T, et al. Telomerase activity in human intestine. Int J Oncol. 1996; 9(3): 453-8. DOI: 10.3892/ijo.9.3.453.10.3892/ijo.9.3.453
- 16. Zhang F, Huber O, Ménard L, et al. Pontin and reptin, two related ATPases with multiple roles in cancer. Cancer Res. 2008; 68(17):6873-6. DOI: 10.1158/0008-5472.CAN-08-0547.10.1158/0008-5472.CAN-08-0547
- 17. Zhang F, Cheng D, Wang S, Zhu J. Human Specific Regulation of the Telomerase Reverse Transcriptase Gene. Genes (Basel). 2016; 7(7). pii: E30. DOI: 10.3390/genes7070030.10.3390/genes7070030
- 18. Yoshida K, Sugino T, Goodison S, et al. Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br J Cancer. 1997; (75) 548-553. DOI:10.1038/bjc.1997.96.10.1038/bjc.1997.96
- 19. Myung SJ, Yang SK, Chang HS, et al. Clinical usefulness of telomerase for the detection of colon cancer in ulcerative colitis patients. J Gastroenterol Hepatol. 2005; (20)1578-1583. DOI: 10.1111/j.1440-1746.2005.03877.x.10.1111/j.1440-1746.2005.03877.x
- 20. Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell. 1997; 90(4):785-95. DOI: http://dx.doi.org/10.1016/S00928674(00)80538-3.10.1016/S00928674(00)80538-3
- 21. Frost M, Bobak JB, Gianani R, et al. Localization of telomerase hTERT protein and hTR in benign mucosa, dysplasia, and squamous cell carcinoma of the cervix. Am J Clin Pathol. 2000; 114(5): 726-34. DOI:10.1309/XWFE-ARMN-HG2D-AJYV.10.1309/XWFE-ARMN-HG2D-AJYV11068546
- 22. Yokoyama Y, Takahashi Y, Shinohara A, et al. Telomerase activity in the female reproductive tract and neoplasms. Gynecol Oncol. 1998; 68:145-9 DOI:10.1006/gyno.1997.4921.10.1006/gyno.1997.49219514809
- 23. Kyo S, Takakura M, Kohama T, et al. Telomerase activity in human endometrium Cancer Res. 1997; 57:610-4.
- 24. Yokoyama Y, Takahashi Y, Morishita S, et al. Telomerase activity in the human endometrium throughout the menstrual cycle. Mol Hum Reprod. 1998; 4:173-7. DOI: 10.1093/molehr/4.2.173.10.1093/molehr/4.2.1739542976
- 25. Gorham H, Yoshida K, Sugino T, et al. Telomerase activity in human gynecological malignancies. J Clin Pathol. 1997; 50:501-4. DOI: 10.1136/jcp.50.6.501.10.1136/jcp.50.6.5014999879378818
- 26. Brien TP, Kallakury BV, Lowry CV, et al. Telomerase activity in benign endometrium and endometrial carcinoma. Cancer Res. 1997; 57: 2760-64.
- 27. Nobre RJ, de Almeida LP, Martins TC. Complete genotyping of mucosal human papillomavirus using a restriction fragment length polymorphism analysis and an original typing algorithm. J Clin Virol. 2008; 42(1):13-21. DOI: 10.1016/j.jcv.2007.11.021.10.1016/j.jcv.2007.11.02118304866
- 28. Saleh S, Lam AK, Ho YH. Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer. Pathology. 2008; 40(1):25-30. DOI: 10.1080/00313020701716425.10.1080/0031302070171642518038311
- 29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25(4):402-8. DOI: 10.1006/meth.2001.1262.10.1006/meth.2001.126211846609
- 30. Branca M, Giorgi C, Ciotti M, et al. Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer. Diagn Cytopathol. 2006; 34(11):739-48. DOI: 10.1002/dc.20554.10.1002/dc.2055417041957
- 31. Hsu CG, Wang PH, Ko JL, et al. Concurrent high expression of human telomerase reverse transcriptase and human non metastatic clone 23 in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of uterine cervix. Int J Gynecol Cancer. 2007;17(4):851-7. DOI:10.1111/j.1525-1438.2007.00894.x.10.1111/j.1525-1438.2007.00894.x17359290
- 32. Wang HY, Park S, Kim S, et al. Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors. Am J Clin Pathol. 2015; 143(3):344-51. DOI:10.1309/AJCPF2XGZ2XIQYQX.10.1309/AJCPF2XGZ2XIQYQX25696792
- 33. Saretzki G, Fischer H, Kaufmann IG, et al. Telomerase activity in cervical smears. Anal Cell Pathol. 2001; 23(1):39-43. DOI: 10.1155/2001/630972.10.1155/2001/630972461882211790858
- 34. Reesink-Peters N, Helder MN, Wisman GB, et al. Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia. J Clin Pathol. 2003; 56(1):31-5. DOI:10.1136/jcp.56.1.31.10.1136/jcp.56.1.31176985512499429
- 35. Nagai N, Oshita T, Murakami J, et al. Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions. Oncol Rep. 1999; 6(2):325-8. DOI:10.3892/or.6.2.325.10.3892/or.6.2.325
- 36. Reddy VG, Khanna N, Jain SK, et al. Telomerase-A molecular marker for cervical cancer screening. Int J Gynecol Cancer. 2001; 11(2):100-6. DOI: 10.1046/j.1525-1438.2001.00095.x.10.1046/j.1525-1438.2001.00095.x
- 37. Castro-Duque AF, Loango-Chamorro N, Ruiz-Hoyos BM, et al. Telomerase activity associated with progression of cervical lesions in a group of Colombian patients. Rev Bras Ginecol Obstet. 2015; 37(12):559-64. DOI: 10.1590/SO100-720320150005462.10.1590/SO100-720320150005462
- 38. Kyo S, Takakura M, Tanaka M, et al. Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions. Int J Cancer. 1998; 79(1):66-70. DOI: 10.1002/(SICI)1097-0215(19980220)79:1<66::AID-IJC13>3.0.CO;2-F.10.1002/(SICI)1097-0215(19980220)79:1<66::AID-IJC13>3.0.CO;2-
- 39. Takakura M, Kyo S, Kanaya T, et al. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res. 1998; 58(7):1558-61.
- 40. Ault KA, Allen HK, Phillips SL, et al. Telomerase activity as a potential diagnostic marker for triage of abnormal Pap smears. J Low Genit Tract Dis. 2005; 9(2):93. DOI: 10.1097/00128360-200504000-00005.10.1097/00128360-200504000-00005
- 41. Kailash U, Soundararajan CC, Lakshmy R, et al. Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer. Br J Cancer. 2006;95(9):1250-7. DOI:10.1038/sj.bjc.6603375.10.1038/sj.bjc.6603375
- 42. Cong YS, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev. 2002;66(3):407-25. DOI: 10.1128/MMBR.66.3.407-425.2002.10.1128/MMBR.66.3.407-425.2002
- 43. Cao Y, Bryan TM, Reddel RR. Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells. Cancer Sci. 2008; 99(6):1092-9. DOI: 10.1111/j.1349-7006.2008.00815.x.10.1111/j.1349-7006.2008.00815.x
- 44. Klingelhutz AJ, Foster SA, McDougall JK. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature. 1996; 380(6569):79-82. DOI:10.1038/380079a0.10.1038/380079a0
- 45. Huang PS, Patrick DR, Edwards G, et al. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Mol Cell Biol. 1993; 13(2):953-60. DOI: 10.1128/MCB.13.2.953.10.1128/MCB.13.2.953
- 46. Oh ST, Kyo S, Laimins LA. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites. J Virol. 2001; 75(12):5559-66. DOI:10.1128/JVI.75.12.5559-5566.2001.10.1128/JVI.75.12.5559-5566.200111426811356963
- 47. Cullen AP, Reid RI, Campion MI, et al. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol. 1991;65(2):606-12.10.1128/jvi.65.2.606-612.1991
- 48. Doorbar J, Quint W, Banks L, et al. The biology and life-cycle of human papillomaviruses. Vaccine. 2012; 30:F55-70. DOI: 10.1016/j.vaccine.2012.06.083.10.1016/j.vaccine.2012.06.08323199966
- 49. Wang SZ, Sun JH, Zhang W, et al. Telomerase activity in cervical intraepithelial neoplasia. Chin Med J (Engl). 2004; 117(2):202-6.
- 50. Snijders PJ, van Duin M, Walboomers JM, et al. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA. Cancer Res. 1998; 58(17):3812-8.